Product Description
Anti-TNFRSF8 (cCA10) -β-glucuronide-doxorubicin propyloxazoline (DPO) ADC | ADC-W-353 | Creative Biolabs
Short Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cCA10) conjugated via a β-glucuronide linker to a doxorubicin propyloxazoline (DPO)
Status: In stock
Expected Delivery Time: 9-11Weeks